{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:48:30Z","timestamp":1773809310412,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To critically review data published in the recent past to scrutinize a causal relationship between retinal vascular occlusion and COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>A comprehensive literature search was performed on Pubmed with the key words retinal vascular occlusion, retinal vein occlusion, retinal artery occlusion, and COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 17 case reports were published during this period, and 10 were on retinal vein occlusion and 7 on retinal artery occlusion. Most of the published reports lacked convincing evidences in one or the other aspects, such as insufficient laboratory workup or presence of multiple confounding risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In this index article, strength of the data is insufficient to establish a definitive cause-and-effect relationship of retinal vascular occlusive disorders with COVID-19. Hence, clinicians can continue to manage these cases according to the standard guidelines until there are more robust evidences to support this association to alter the diagnostic and treatment modalities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003371","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T23:01:20Z","timestamp":1639609280000},"page":"413-416","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["MYTHS AND TRUTHS OF THE ASSOCIATION OF RETINAL VASCULAR OCCLUSION WITH COVID-19"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-9791","authenticated-orcid":false,"given":"Ashish","family":"Sharma","sequence":"first","affiliation":[{"name":"Lotus Eye Hospital and Institute, Coimbatore, Tamil Nadu, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikulaa","family":"Parachuri","sequence":"additional","affiliation":[{"name":"Lotus Eye Hospital and Institute, Coimbatore, Tamil Nadu, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Lotus Eye Hospital and Institute, Coimbatore, Tamil Nadu, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Rosario","family":"Romano","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Humanitas University, Milan, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Parolini","sequence":"additional","affiliation":[{"name":"Eyecare Clinic, Brescia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sengul","family":"Ozdek","sequence":"additional","affiliation":[{"name":"Ophthalmology, Gazi University, School of Medicine, Ankara, Turkey;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Tawfik","sequence":"additional","affiliation":[{"name":"Marashi Eye Clinic, Aleppo, Syria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameen","family":"Marashi","sequence":"additional","affiliation":[{"name":"Memorial Institute of Ophthalmology Research, Cairo, Giza, Egypt;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baruch D.","family":"Kuppermann","sequence":"additional","affiliation":[{"name":"Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Stanford University, Palo Alto, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1080\/09273948.2020.1807023","article-title":"Impending central retinal vein occlusion in a patient with coronavirus disease 2019 (COVID-19)","volume":"28","author":"Invernizzi","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"e927691","DOI":"10.12659\/AJCR.927691","article-title":"Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia","volume":"21","author":"Gaba","year":"2020","journal-title":"Am J Case Rep"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"e1246","DOI":"10.1111\/aos.14718","article-title":"Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19","volume":"99","author":"Rego Lorca","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.4103\/ijo.IJO_2575_20","article-title":"Central retinal vein occlusion with COVID-19 infection as the presumptive etiology","volume":"68","author":"Walinjkar","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/taap.2001.9356","article-title":"Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease","volume":"179","author":"Lee","year":"2002","journal-title":"Toxicol Appl Pharmacol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"377.e1","DOI":"10.1016\/j.ajog.2012.08.007","article-title":"Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008","volume":"207","author":"Okoroh","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"100992","DOI":"10.1016\/j.ajoc.2020.100992","article-title":"Central retinal vein occlusion in a young healthy COVID-19 patient: a case report","volume":"20","author":"Yahalomi","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R8-20250607","first-page":"109","article-title":"Retinal vein occlusion","volume":"42","author":"Hayreh","year":"1994","journal-title":"Indian J Ophthalmol"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/ijo.IJO_2380_20","article-title":"Retinal vein occlusion in COVID-19: a novel entity","volume":"68","author":"Sheth","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"101046","DOI":"10.1016\/j.ajoc.2021.101046","article-title":"Hemi-retinal vein occlusion in a young patient with COVID-19","volume":"22","author":"Finn","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"e242987","DOI":"10.1136\/bcr-2021-242987","article-title":"COVID-19-associated central retinal vein occlusion treated with oral aspirin","volume":"14","author":"Venkatesh","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12348-021-00241-7","article-title":"Central retinal vein occlusion in the setting of COVID-19 infection","volume":"11","author":"Raval","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R13-20250607","first-page":"e13586","article-title":"Branch retinal vein occlusion in a COVID-19 positive patient","volume":"13","author":"Duff","year":"2021","journal-title":"Cureus"},{"key":"R14-20250607","first-page":"1120672121995347","article-title":"Paracentral acute middle maculopathy in the setting of central retinal artery occlusion following COVID-19 diagnosis","author":"Turedi","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"106440","DOI":"10.1016\/j.clineuro.2020.106440","article-title":"Monocular visual loss as the presenting symptom of COVID-19 infection","volume":"201","author":"Murchison","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"R16-20250607","first-page":"2515841419838661","article-title":"Unilateral cilioretinal artery occlusion following cannabis use","volume":"11","author":"Ugradar","year":"2019","journal-title":"Ther Adv Ophthalmol"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4103\/ijo.IJO_563_21","article-title":"Cilioretinal artery occlusion with paracentral acute middle maculopathy associated with COVID-19","volume":"69","author":"Ozsayg\u0131l\u0131","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R18-20250607","first-page":"1","article-title":"Simultaneous bilateral central retinal artery occlusion following COVID-19 infection","author":"Bapaye","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"e00867","DOI":"10.1016\/j.idcr.2020.e00867","article-title":"Unique case of central retinal artery occlusion secondary to COVID-19 disease","volume":"21","author":"Acharya","year":"2020","journal-title":"IDCases"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1055\/a-1353-5915","article-title":"Bilateral central retinal artery occlusion secondary to SARS-CoV-2 infection in the early and late periods: a case report","volume":"238","author":"Karahan","year":"2021","journal-title":"Klin Monbl Augenheilkd"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"588384","DOI":"10.3389\/fphar.2020.588384","article-title":"Case report: central retinal artery occlusion in a COVID-19 patient","volume":"11","author":"Montesel","year":"2020","journal-title":"Front Pharmacol"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4103\/ijo.IJO_88_21","article-title":"Prevalence of SARS-CoV-2 among central retinal vein occlusion patients","volume":"69","author":"Sunny","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/CH-209007","article-title":"COVID-19 and the endothelium","volume":"75","author":"Jung","year":"2020","journal-title":"Clin Hemorheol Microcirc"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:02:44Z","timestamp":1749319364000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003371","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}